Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1011610

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that cystic fibrosis sufferers have access to Orkambi.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	194005
answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) and NHS England are in dialogue with Vertex Pharmaceuticals around access to their portfolio of cystic fibrosis medicines. It is critical that Vertex now re-engages fully with the NICE appraisal process and gives serious consideration to the portfolio deal offer that NHS England made at the end of July. This deal would provide immediate access for patients to all Vertex licensed medicines and future pipeline products once licensed and in advance of the individual NICE appraisals concluding.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2018 16:56:46 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake

1011611

registered interest
date	21/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will introduce a new 5-year survival target of 28 per cent by 2029 for (a) lung, (b) liver, (c) brain, (d) oesophageal, (e) pancreatic and (f) stomach cancer.
tabling member constituency	Carshalton and Wallington
tabling member printed	Tom Brake
uin	194006
answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The Prime Minister announced ambitions for the National Health Service Long Term Plan that will see 55,000 more people surviving cancer for five years in England each year from 2028 and three quarters of all cancers detected at an early stage by 2028. To achieve these ambitions, we will need to make signification progress on survival across all cancers, including lung, liver, brain, oesophageal, pancreatic and stomach cancers.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2018 17:24:18 answering member 4067 label Biography information for Steve Brine
tabling member	151 label Biography information for Tom Brake